FINNENCE ▪ THE WIRE FILE
THE WIRE · № 79020
News■ Unclear/unknown
Australian court dismisses Cosette appeal to drop Mayne Pharma takeover
KINDNews
DIRECTION■ Unclear/unknown
SOURCES1
ENTITIES1
STORY SIZESTANDALONE
FIRST SEEN
LAST UPDATE
STATEactive
01 THE MACHINE READ
WHY IT MATTERS.
A dismissed appeal clears the Mayne Pharma takeover path, a narrow single-name M&A development.
Mayne Pharma deal path cleared
CATALYST TO WATCH
Completion or revised offer terms
MAIN RISK
Deal could still face other hurdles
02 THE STORY SO FAR
THE RECORD, IN ORDER.
STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.
03 WHO'S INVOLVED
ENTITIES ON FILE.
AFFECTEDHealthcare
04 RECEIPTS
THE SOURCE RECORD.
1 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
→CORRELATIONshares Healthcare
Telix Highlights Pivotal Trials in Prostate, Brain and Renal Cancers and Next Generation Theranostics at EANM2026-10-14 05:00 UTC
Telix Highlights Pivotal Trials in Prostate, Brain and Renal Cancers and Next Generation Theranostics at EANM2026-10-14 05:00 UTC
→CORRELATIONshares Healthcare
MindMaze Therapeutics Reports New Home-Based Rehabilitation Results Ahead of MindMotion Lite Launch2026-10-14 05:37 UTC
MindMaze Therapeutics Reports New Home-Based Rehabilitation Results Ahead of MindMotion Lite Launch2026-10-14 05:37 UTC
→CORRELATIONshares Healthcare
From Hospital AI to Home Monitoring: Taiwan's Health-Tech Sector Tests Its U.S. Market Fit in Dallas2026-10-14 05:55 UTC
From Hospital AI to Home Monitoring: Taiwan's Health-Tech Sector Tests Its U.S. Market Fit in Dallas2026-10-14 05:55 UTC
→CORRELATIONshares Healthcare
About 11% of U.S. adults now take a GLP-1 drug for weight loss, roughly 28 million people, according to Gallup.2026-10-14 03:31 UTC
About 11% of U.S. adults now take a GLP-1 drug for weight loss, roughly 28 million people, according to Gallup.2026-10-14 03:31 UTC
→CORRELATIONshares Healthcare
Danaher Collaborates with NVIDIA to Advance Autonomous Science2026-10-14 06:00 UTC
Danaher Collaborates with NVIDIA to Advance Autonomous Science2026-10-14 06:00 UTC
←CORRELATIONshares Healthcare
Johnson & Johnson CFO Joseph Wolk: 'You can't heap enough praise on the pharma unit'2026-10-13 16:30 UTC
Johnson & Johnson CFO Joseph Wolk: 'You can't heap enough praise on the pharma unit'2026-10-13 16:30 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors — every claim links its sources.